Mizuho expects limited upside potential; Guggenheim lifts price target on AAPL, predicting key upside ahead.
Paratek Pharmaceuticals Inc (NASDAQ:PRTK) shares rose by nearly 31% after the microcap acne medicine maker announced a positive top-line Phase 3 data readout …
In a research report released today, Guggenheim analyst Louise Chen initiated coverage on shares of Opko Health Inc. (NASDAQ:OPK) with a Buy rating and price target …
RH (NYSE:RH) shares jumped around 20% this morning after the home design company reported preliminary sales and earnings results for 4Q16, coming in ahead …
The tech-verse is brimming with anticipation for a double-earnings release tonight for two of its leading giants, Amazon.com, Inc.
Guggenheim analyst Louise Chen was out with a research note on shares of Aralez Pharmaceuticals Inc (NASDAQ:ARLZ), reiterating a Buy rating and price target of …
Guggenheim analyst William Tanner was out pounding the table on Novavax, Inc. (NASDAQ:NVAX) Friday, reiterating a Buy rating and price target of $25, which implies an …
Analysts are weighing in today on drug maker Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and fitness tech firm Fitbit Inc (NYSE:FIT). Here’s a quick roundup of today’s bullish brokerage …
Guggenheim analyst Michael Morris was out pounding the table on Netflix, Inc. (NASDAQ:NFLX) Friday, reiterating a Buy rating and price target of $160, which …
